BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32811600)

  • 1. Prognostic Value of ABO Blood Groups in Patients with Glioblastoma Multiforme.
    Sokmen FC; Karacin C
    J Coll Physicians Surg Pak; 2020 Jul; 30(7):713-716. PubMed ID: 32811600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide.
    Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Ciner F; Mertsoylu H; Tufan K
    J Neurooncol; 2018 Sep; 139(2):411-419. PubMed ID: 29696530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
    Konar SK; Bir SC; Maiti TK; Nanda A
    J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of surgery on the efficacy of adjuvant therapy in glioblastoma multiforme.
    Brzozowska A; Toruń A; Mazurkiewicz M
    Adv Clin Exp Med; 2015; 24(2):279-87. PubMed ID: 25931361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study.
    Pessina F; Navarria P; Cozzi L; Tomatis S; Riva M; Ascolese AM; Santoro A; Simonelli M; Bello L; Scorsetti M
    J Neurooncol; 2017 Jan; 131(2):377-384. PubMed ID: 27826681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.
    Seidlitz A; Siepmann T; Löck S; Juratli T; Baumann M; Krause M
    Radiat Oncol; 2015 Aug; 10():172. PubMed ID: 26276734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
    Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
    J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcome and prognostic factors of adult glioblastoma multiforme.
    Ahmadloo N; Kani AA; Mohammadianpanah M; Nasrolahi H; Omidvari S; Mosalaei A; Ansari M
    J Egypt Natl Canc Inst; 2013 Mar; 25(1):21-30. PubMed ID: 23499203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study.
    Kim YS; Kim SH; Cho J; Kim JW; Chang JH; Kim DS; Lee KS; Suh CO
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):661-7. PubMed ID: 22414280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
    Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
    Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.
    Brenner A; Friger M; Geffen DB; Kaisman-Elbaz T; Lavrenkov K
    Oncology; 2019; 97(5):255-263. PubMed ID: 31288238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
    Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
    J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.
    Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
    J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
    Hao Y; Li X; Chen H; Huo H; Liu Z; Tian F; Chai E
    World Neurosurg; 2019 Aug; 128():e427-e433. PubMed ID: 31042598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes of giant cell glioblastoma: institutional experience in the management of 20 patients.
    Oh T; Rutkowski MJ; Safaee M; Sun MZ; Sayegh ET; Bloch O; Tihan T; Parsa AT
    J Clin Neurosci; 2014 Dec; 21(12):2129-34. PubMed ID: 25037316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival Analysis of Glioblastoma Multiforme.
    Witthayanuwat S; Pesee M; Supaadirek C; Supakalin N; Thamronganantasakul K; Krusun S
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2613-2617. PubMed ID: 30256068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.